Advertisement
Full Length Article| Volume 35, ISSUE 4, P507-515, October 2022

Download started.

Ok

Combination therapy with repetitive facilitative exercise program and botulinum toxin type A to improve motor function for the upper-limb spastic paresis in chronic stroke: A randomized controlled trial

Published:January 26, 2021DOI:https://doi.org/10.1016/j.jht.2021.01.005

      Highlights

      • Forty chronic stroke patients with upper-limb spastic paresis were enrolled an RCT.
      • Control group (CG) received repetitive facilitative exercise (RFE) program only.
      • Intervention group (IG) received BoNT-A injection combined with the RFE program.
      • Motor control and motor functions were evaluated during 4-week study period.
      • IG evidenced significantly greater improvement in the outcome measures than CG.

      Abstract

      Study design

      An open-label, randomized, controlled, observer-blinded trial.

      Introduction

      Repetitive facilitative exercise (RFE) is a movement therapy to recover from hemiparesis after stroke. However, improvement is inhibited by spasticity. Recently, botulinum toxin type A (BoNT-A) injection has been shown to reduce spasticity.

      Purpose

      To examine the combined effect of an RFE program and BoNT-A treatment on upper-limb spastic paresis in chronic stroke.

      Methods

      Forty chronic stroke inpatients with upper-limb spastic paresis (Brunnstrom stage ≥III and Modified Ashworth Scale [MAS] score ≥1) were enrolled. Subjects were randomized into 2 groups of 20 each and received 4 weeks of treatment. The intervention group received RFE and BoNT-A injection; the control group underwent RFE only. Assessments were performed at baseline and at study conclusion. The primary outcome was change in Fugl–Meyer Assessment score for the upper extremity (FMA). The Action Research Arm Test (ARAT), active range of motion, Box and Block Test, and MAS were also evaluated.

      Results

      All participants completed this study. After 4 weeks, the intervention group evidenced a significantly greater increase in FMA score (median 11.0 [range 4-20]) than the control group (median 3.0 [range 0-9]) (P < .01, r = 0.79); as well as improvements in the other measures such as ARAT (median 12.5 [range 4-22] vs 7 [0-13]) (P < .01, r = 0.6), and MAS in the elbow flexors (median −1.5 [range −2 to 0] vs −1 [−2 to 0]) (P < .01, r = 0.45).

      Discussion

      A high degree of repetitive volitional movement induced by the facilitative technique with concomitant control of spasticity by BoNT-A injection might increase efficiency of motor learning with continuous movement of the affected upper-limb.

      Conclusions

      The combination of RFE and BoNT-A for spastic paresis might be more effective than RFE alone to improve upper-limb motor function and to lessen impairment in chronic stroke.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hand Therapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Pollock A
        • Farmer SE
        • Brady MC
        • et al.
        Interventions for improving upper limb function after stroke.
        Cochrane Database Syst Rev. 2014; 12CD010820
        • Asanuma H
        • Keller A
        Neuronal mechanisms of motor learning in mammals.
        Neuroreport. 1991; 2: 217-224
        • Kawahira K
        Exercise Therapy for Motor Recovery From Hemiplegia: Theory and Technique of Repetitive Facilitative Exercise.
        First edition. Igaku-shoin, Tokyo2006 (in Japanese)
        • Kawahira K
        • Shimodozono M
        • Etoh S
        • Kamada K
        • Noma T
        • Tanaka N
        Effects of intensive repetition of a new facilitation technique on motor functional recovery of the hemiplegic upper limb and hand.
        Brain Inj. 2010; 24: 1202-1213
        • Shimodozono M
        • Noma T
        • Nomoto Y
        • et al.
        Benefits of a repetitive facilitative exercise program for the upper paretic extremity after subacute stroke: a randomized controlled trial.
        Neurorehabil Neural Repair. 2013; 27: 296-305
        • Working group on guidelines for the management of stroke
        Japanese Guidelines for the Management of Stroke 2015..
        Kyowa-Kikaku, Tokyo, Japan2015 (in Japanese)
        • Lance JW
        Disordered muscle tone and movement.
        Clin Exp Neurol. 1981; 18: 27-35
        • Sommerfeld DK
        • Eek EU
        • Svensson AK
        • Holmqvist LW
        • von Arbin MH
        Spasticity after stroke: its occurrence and association with motor impairments and activity limitations.
        Stroke. 2004; 35: 134-139
        • Lundstrom E
        • Terent A
        • Borg J
        Prevalence of disabling spasticity 1 year after first-ever stroke.
        Eur J Neurol. 2008; 15: 533-539
        • Lin FM
        • Sabbahi M
        Correlation of spasticity with hyperactive stretch reflexes and motor dysfunction in hemiplegia.
        Arch Phys Med Rehabil. 1999; 80: 526-530
        • Doan QV
        • Brashear A
        • Gillard PJ
        • et al.
        Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity.
        PM R. 2012; 4: 4-10
        • Zorowitz RD
        • Gillard PJ
        • Brainin M
        Poststroke spasticity: sequelae and burden on stroke survivors and caregivers.
        Neurology. 2013; 80: S45-S52
        • Simpson DM
        • Alexander DN
        • O'Brien CF
        • et al.
        Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial.
        Neurology. 1996; 46: 1306-1310
        • Bhakta BB
        • Cozens JA
        • Chamberlain MA
        • Banford JM
        Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomized double blind placebo controlled trial.
        J Neurol Neurosurg Psychiatry. 2000; 69: 217-221
        • Bensmail D
        • Robertson JV
        • Fermanian C
        • Roby-Brami A
        Botulinum toxin to treat upper-limb spasticity in hemiparetic patients: analysis of function and kinematics of reaching movements.
        Neurorehabil Neural Repair. 2010; 24: 273-281
        • Hatem SM
        • Saussez G
        • Della Faille M
        • et al.
        Rehabilitation of motor function after stroke: a multiple systematic review focused on techniques to stimulate upper extremity recovery.
        Front Hum Neurosci. 2016; 10: 442https://doi.org/10.3389/fnhum.2016.00442
        • Hirakawa Y
        • Koyama S
        • Tanabe S
        • et al.
        Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: a case report.
        J Hand Ther. 2019; 32: 519-524
        • Sun SF
        • Hsu CW
        • Sun HP
        • Hwang CW
        • Yang CL
        • Wang JL
        Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
        Neurorehabil Neural Repair. 2010; 24: 34-41
        • Teasell R
        • Foley N
        • Pereira S
        • Sequeira K
        • Miller T
        Evidence to practice: botulinum toxin in the treatment of spasticity post stroke.
        Top Stroke Rehabil. 2012; 19: 115-121
        • Mills PB
        • Finlayson H
        • Sudol M
        • O'Connor R
        Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity.
        Clin Rehabil. 2016; 30: 537-548
        • Dong Y
        • Wu T
        • Hu X
        • Wang T
        Efficacy and safety of botulinum toxin type A for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis.
        Eur J Phys Rehabil Med. 2017; 53: 256-267
        • Levy J
        • Molteni F
        • Cannaviello G
        • Lansaman T
        • Roche N
        • Bensmail D
        Does botulinum toxin treatment improve upper limb active function?.
        Ann Phys Rehabil Med. 2018; 27 (pii: S1877-0657)
        • Brunnstrom S
        Motor testing procedures in hemiplegia: based on sequential recovery stages.
        Phys Ther. 1966; 46: 357-375
        • Bohannon RW
        • Smith MB
        Interrater reliability of a modified Ashworth scale of muscle spasticity.
        Phys Ther. 1987; 67: 206-207
        • Shimodozono M
        • Noma T
        • Matsumoto S
        • Miyata R
        • Etoh S
        • Kawahira K
        Repetitive facilitative exercise under continuous electrical stimulation for severe arm impairment after sub-acute stroke: a randomized controlled pilot study.
        Brain Inj. 2014; 28: 203-210
        • Fugl-Meyer AR
        • Jääskö L
        • Leyman I
        • Olsson S
        • Steqlind S
        The post-stroke hemiplegic patient. 1. A method for evaluation of physical performance.
        Scand J Rehabil Med. 1975; 7: 13-31
        • Yozbatiran N
        • Der-Yeghiaian L
        • Cramer SC
        A standardized approach to performing the action research arm test.
        Neurorehabil Neural Repair. 2008; 22: 78-90
        • Mathiowetz V
        • Volland G
        • Kashman N
        • Weber K
        Adult norms for the Box and Block Test of manual dexterity.
        Am J Occup Ther. 1985; 39: 386-391
        • Chua KS
        • Kong KH
        • Lui YC
        Botulinum toxin A in the treatment of hemiplegic spastic foot drop–clinical and functional outcomes.
        Singapore Med J. 2000; 41: 209-213
        • Cohen J
        Statistical Power Analysis for the Behavioral Sciences.
        2nd ed. Lawrence Erlbaum Associates, Hillsdale, NJ1988
        • Page SJ
        • Fulk GD
        • Boyne P
        Clinically important differences for the upper-extremity Fugl-Meyer Scale in people with minimal to moderate impairment due to chronic stroke.
        Phys Ther. 2012; 92: 791-798
        • Van der Lee JH
        • De Groot V
        • Beckerman H
        • Wagenaar RC
        • Lankhorst GJ
        • Bouter LM
        The intra- and interrater reliability of the action research arm test: a practical test of upper extremity function in patients with stroke.
        Arch Phys Med Rehabil. 2001; 82: 14-19
        • Grigoriu AI
        • Dinomais M
        • Remy-Neris O
        • Brochard S
        Impact of injection-guiding techniques on the effectiveness of botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review.
        Arch Phys Med Rehabil. 2015; 96: 2067-2078
        • Noma T
        • Kamada K
        • Kai Y
        • et al.
        Effects of combined therapy of repetitive facilitation exercise and antispastic vibratory stimuli on motor functional recovery of hemiplegic upper limb in patients with stroke.
        Sogo Rehabil. 2009; 37 (in Japanese): 137-143
        • Etoh S
        • Noma T
        • Ikeda K
        • et al.
        Effects of repetitive trascranial magnetic stimulation on repetitive facilitation exercises of the hemiplegic hand in chronic stroke patients.
        J Rehabil Med. 2013; 45: 843-847
        • Etoh S
        • Noma T
        • Takiyoshi Y
        • et al.
        Effects of repetitive facilitative exercise with neuromuscular electrical stimulation, vibratory stimulation and repetitive transcranial magnetic stimulation of the hemiplegic hand in chronic stroke patients.
        Int J Neurosci. 2016; 126: 1007-1012
        • Noma T
        • Matsumoto S
        • Shimodozono M
        • Etoh S
        • Kawahira K
        Anti-spastic effects of the direct application of vibratory stimuli to the spastic muscles of hemiplegic limbs in post-stroke patients: a proof-of- principle study.
        J Rehabil Med. 2012; 44: 325-330
        • Meythaler JM
        • Vogtle L
        • Brunner RC
        A preliminary assessment of the benefits of the addition of botulinum toxin a to a conventional therapy program on the function of people with longstanding stroke.
        Arch Phys Med Rehabil. 2009; 90: 1453-1461
        • Renner CI
        • Schubert M
        • Hummelsheim H
        Selective effect of repetitive hand movements on intracortical excitability.
        Muscle Nerve. 2005; 31: 314-320
        • Page SJ
        • Elovic E
        • Levine P
        • Sisto SA
        Modified constraint-induced therapy and botulinum toxin A: a promising combination.
        Am J Phys Med Rehabil. 2003; 82: 76-80
        • Vinstrup J
        • Calatayud J
        • Jakobsen MD
        • et al.
        Hand strengthening exercises in chronic stroke patients: dose-response evaluation using electromyography.
        J Hand Ther. 2018; 31: 111-121
        • Cantero-Téllez R
        • Naughton N
        • Algar L
        • Valdes K
        Outcome measurement of hand function following mirror therapy for stroke rehabilitation: A systematic review.
        J Hand Ther. 2019; 32: 277-291
        • Orihuela-Espina F
        • Roldán GF
        • Sánchez-Villavicencio I
        • et al.
        Robot training for hand motor recovery in subacute stroke patients: A randomized controlled trial.
        J Hand Ther. 2016; 29: 51-57
        • Albright AL
        • Barron WB
        • Fasick MP
        • Polinko P
        • Janosky J
        Continuous intrathecal baclofen infusion for spasticity of cerebral origin.
        JAMA. 1993; 270: 2475-2477
        • Taub E
        • Uswatte G
        • Mark VW
        • Morris DM
        The learned nonuse phenomenon: implications for rehabilitation.
        Eura Medicophys. 2006; 42: 241-256
        • Etoh S
        • Noma T
        • Miyata R
        • Shimodozono M
        Effects of repetitive facilitative exercise on spasticity in the upper paretic limb after subacute stroke.
        J Stroke Cerebrovasc Dis. 2018; 27: 2863-2868
        • Huyuh W
        • Krishnan AV
        • Lin CS
        • et al.
        Botulinum toxin modulates cortical maladaptation in post-stroke spasticity.
        Muscle Nerve. 2013; 48: 93-99
        • Veverka T
        • Hlustik P
        • Hok P
        • et al.
        Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
        J Neurol Sci. 2014; 346: 276-283
        • Lee JM
        • Gracies JM
        • Park SB
        • Lee KH
        • Lee JY
        • Shin JH
        Botulinum toxin injections and electrical stimulation for spastic paresis improve active hand function following stroke.
        Toxins. 2018; 10 (pii: E426)https://doi.org/10.3390/toxins10110426
        • Hara T
        • Abo M
        • Hara H
        • et al.
        The effect of repeated botulinum toxin A therapy combined with intensive rehabilitation on lower limb spasticity in post-stroke patients.
        Toxins. 2018; 10 (pii: E349)https://doi.org/10.3390/toxins10090349

      JHT Read for Credit

      Quiz: # 915

      Record your answers on the Return Answer Form found on the tear-out coupon at the back of this issue or to complete online and use a credit card, go to JHTReadforCredit.com. There is only one best answer for each question.
      • # 1.
        The study design is
        • a.
          qualitative
        • b.
          RCTs
        • c.
          case series
        • d.
          n = 1
      • # 2.
        BoNT-A was used because of its reputation for
        • a.
          enhancing proprioception
        • b.
          improving motor power
        • c.
          eliminating spasticity
        • d.
          reducing spasticity
      • # 3.
        The control group received
        • a.
          neither the RFE nor the BoNT-A
        • b.
          both the RFE and the BoNT-A
        • c.
          only the RFE
        • d.
          only the BoNT-A
      • # 4.
        The outcome measure was the
        • a.
          Brunnstrom Function Assessment
        • b.
          FMA
        • c.
          AMF
        • d.
          DASH
      • # 5.
        The combined therapies were definitively shown to be effective
        • a.
          not true
        • b.
          true
      When submitting to the HTCC for re-certification, please batch your JHT RFC certificates in groups of 3 or more to get full credit.